Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round of private financing led by S2G Ventures, bringing total funding to date to $67 million. The proceeds of the financing will ...
Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired NextHealth Technologies, an AI-powered SaaS-based healthcare analytics platform. With the acquisition, Softheon will be better able to help health plans sell ...
ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment of Paul August, Ph.D., as the Chief Scientific Officer. “We are thrilled to welcome Dr. August to our team,” said Peng Yue, ...
Popular Posts
